FindTrial
Sign In

The use of gastric content to predict poor outcomes in medical critically ill patients

The use of gastric content to predict poor outcomes in medical critically ill patients

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20220530004
Enrollment
79
Registered
2022-05-30
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric content critical illness gastric pH poor prognosis outcomes proteomics metabolomics gastric content critical illness gastric pH poor prognosis outcomes proteomics metabolomics

Interventions

The patient who firstly admitted to the ICU. The composite outcomes which consist of 28-day mortality rate, VAP, SRMD, and CDI. Moreover, the proteomics and metabolomics fingerprints as a shotgun ap
Diagnostic
Critical ill patients

Sponsors

The Faculty of Medicine Research Fund
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: The patient who has nasogastric tube insertion on the first day of ICU admission.

Exclusion criteria

Exclusion criteria: The exclusion criteria are the patients who previously received PPIs or anti-histamine-2 receptor (H2RAS), unable to insert an NG tube on the first date, have upper GI bleeding, are pregnant, and refuse to participate in the study.

Design outcomes

Primary

MeasureTime frame
Composite outcomes of death, CDI, VAP, and SRMD 28 days proportion—

Secondary

MeasureTime frame
n/a n/a n/a—

Countries

Thailand

Contacts

Public ContactKanjanaporn Phukpattanachai

FOMCMU

kanjanaporn_phuk@cmu.ac.th0863866125

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026